- Ongoing, recruitingTherapeutic use (Phase IV)
The rimegePant in RElation to obeSiTy in mIGrainE study
This study looks at how a new migraine medication, rimegepant, works differently in people depending on their body weight. Researchers are checking how it affects blood flow in the skin after applying a special cream and using a small electrical pulse.
For: Obesity · MigraineNetherlands - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to traumatic or post-operative peripheral Neuropathy
This study is looking at a new spray (AP707) for chronic pain caused by nerve damage after an injury or surgery. It aims to see how well it works and if it has side effects, compared to a dummy spray, for adults aged 18 and over.
For: Chronic Pain due to traumatic or post-operative peripheral NeuropathyGermany · Austria - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to Diabetic Polyneuropathy
This study is looking for new ways to help people with ongoing pain caused by diabetes affecting their nerves. It's testing a new spray treatment to see if it reduces pain and if it's safe compared to a dummy spray.
For: Chronic pain due to diabetic polyneuropathyAustria · Germany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
An interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial evaluating the efficacy and safety of Qutenza® in subjects with post-surgical neuropathic pain
This study is looking at how well a patch called Qutenza works for nerve pain after surgery. It compares Qutenza to a dummy patch to see if it reduces pain and is safe for people 18 and over.
For: Post-surgical neuropathic painNetherlands · Spain · Poland